Multivariate modeling for survival
| Parameter . | Hazard ratio . | P . |
|---|---|---|
| Female sex | 0.724 | .0359* |
| Age > 65 y | 0.901 | .5666 |
| Melphalan dose < 200 mg/m2 | 1.672 | .0011* |
| Absence of cardiac involvement | 0.792 | .1530 |
| κ-light chain | 0.724 | .1108 |
| Organs involved, number < 3 | 0.529 | .0001* |
| Creatinine < 2 mg/dL | 0.695 | .0564 |
| Alkaline phosphatase < 200 U/L | 1.461 | .0812 |
| Parameter . | Hazard ratio . | P . |
|---|---|---|
| Female sex | 0.724 | .0359* |
| Age > 65 y | 0.901 | .5666 |
| Melphalan dose < 200 mg/m2 | 1.672 | .0011* |
| Absence of cardiac involvement | 0.792 | .1530 |
| κ-light chain | 0.724 | .1108 |
| Organs involved, number < 3 | 0.529 | .0001* |
| Creatinine < 2 mg/dL | 0.695 | .0564 |
| Alkaline phosphatase < 200 U/L | 1.461 | .0812 |
Statistically significant.